Suppressor of Cytokine Signalling 5 (SOCS5) Modulates Inflammatory Responses during Alphavirus Infection

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• Central nervous system (CNS) viral infections pose significant global health risks, causing morbidity and mortality.
• While brain inflammation is protective, uncontrolled immune responses can be detrimental.
• Suppressor of cytokine signalling (SOCS) proteins regulate inflammatory and immune responses, with SOCS5 highly expressed in the brain but poorly understood.

Purpose of the Study:

• To investigate the role of SOCS5 in the pathogenesis of CNS viral infections.
• To determine the impact of SOCS5 deficiency on neuroinflammation and clinical outcomes during viral encephalitis.

Main Methods:

• Utilized a mouse model of viral encephalitis.
• Compared disease progression and immune responses in SOCS5-deficient mice versus wild-type controls.

Main Results:

• SOCS5-deficient mice exhibited exacerbated disease, including greater weight loss.
• Dysregulated cytokine production and increased neuroinflammatory infiltrates (CD11b+ cells) were observed in SOCS5-deficient mice.
• Lack of SOCS5 altered the pathogenesis and clinical outcome of the neurotropic viral infection.

Conclusions:

• SOCS5 acts as a critical regulator of antiviral immunity in the brain.
• SOCS5 is essential for balancing immunopathology and viral persistence during CNS infections.
• Targeting SOCS5 may offer therapeutic potential for managing viral encephalitis.